Skip to main content
NIH Intramural Research Program, Our Research Changes Lives

Navigation controls

  • Search
  • Menu

Social follow links

  • Podcast
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
      • Nobel Prize
      • Lasker Award
      • Breakthrough Prize
      • Presidential Early Career Award for Scientists and Engineers (PECASE)
      • Presidential Medal of Freedom
      • National Medal of Science
      • Searle Scholars
      • The National Academy of Sciences
      • The National Academy of Medicine
      • The National Academy of Engineering
      • The American Academy of Arts and Sciences
      • National Medal of Technology & Innovation
      • Samuel J. Heyman Service to America Medals
      • Crafoord Prize
      • Fellows of the Royal Society
      • Canada Gairdner Awards
    • Organization & Leadership
    • Our Programs
      • NCI
      • NEI
      • NHGRI
      • NHLBI
      • NIA
      • NIAAA
      • NIAID
      • NIAMS
      • NIBIB
      • NICHD
      • NIDA
      • NIDCD
      • NIDCR
      • NIDDK
      • NIEHS
      • NIMH
      • NIMHD
      • NINDS
      • NINR
      • NLM
      • CC
      • NCATS
      • NCCIH
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
      • Biomedical Engineering & Biophysics
      • Cancer Biology
      • Cell Biology
      • Chemical Biology
      • Chromosome Biology
      • Clinical Research
      • Computational Biology
      • Developmental Biology
      • Epidemiology
      • Genetics & Genomics
      • Health Disparities
      • Immunology
      • Microbiology & Infectious Diseases
      • Molecular Biology & Biochemistry
      • Molecular Pharmacology
      • Neuroscience
      • RNA Biology
      • Social & Behavioral Sciences
      • Stem Cell Biology
      • Structural Biology
      • Systems Biology
      • Virology
    • Principal Investigators
      • View by Investigator Name
      • View by Scientific Focus Area
    • Accomplishments
      • View All Accomplishments by Date
      • View All Health Topics
      • The Body
      • Health & Wellness
      • Conditions & Diseases
      • Procedures
    • Accelerating Science
      • Investing in Cutting-Edge Animal Models
      • Creating Cell-Based Therapies
      • Advancing Computational and Structural Biology
      • Combating Drug Resistance
      • Developing Novel Imaging Techniques
      • Charting the Pathways of Inflammation
      • Zooming in on the Microbiome
      • Uncovering New Opportunities for Natural Products
      • Stimulating Neuroscience Research
      • Pursuing Precision Medicine
      • Unlocking the Potential of RNA Biology and Therapeutics
      • Producing Novel Vaccines
    • Research in Action
      • View All Stories
      • Too Much of a Good Thing
      • Turning Face Perception on Its Head
      • Safeguarding a Second Chance at Life
      • A Biological Betrayal
    • Trans-IRP Research Resources
      • Supercomputing
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Advancing Translational Science
    • Clinical Trials
      • Get Involved with Clinical Research
      • Physician Resources
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
      • Stadtman Tenure-Track Investigators
        • Science, the Stadtman Way
        • Earl Stadtman Investigator Frequently Asked Questions
      • Lasker Clinical Research Scholars
      • Independent Research Scholar
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
The NIH Catalyst: A Publication About NIH Intramural Research

National Institutes of Health • Office of the Director | Volume 20 Issue 3 • May–June 2012

Eyes on the Goal

Anand Swaroop Seeks Therapies for Retinal Diseases

By Heather Dolan

“People over 40 are really scared of going blind,” National Eye Institute (NEI) Senior Investigator Anand Swaroop told the scientific directors at their meeting on March 7, 2012. “After cancer and heart disease, blindness is probably the most feared of all.”

He went on to describe his lab’s work on promising stem cell advances that one day might be used to treat blinding neurodegenerative diseases. But Swaroop might not be doing eye research at all if his early career had gone the way he planned.

CHRIS GUNN PHOTOGRAPHY

Senior Investigator Anand Swaroop (NEI) is battling retinal diseases that cause blindness.

When he was doing postdoctoral work in genetics at Yale University (New Haven, Conn.), in the 1980s, he wanted to be the first to find the gene that causes Duchenne muscular dystrophy (DMD). When Louis Kunkel’s group at Children’s Hospital Boston beat him to it and identified the gene in 1986, Swaroop was disheartened.

But not for long. He found a different disease gene to work on: X-linked retinal pigmentosa 3 (RP3). Defects in RP3 and several other genes cause retinitis pigmentosa, genetic eye conditions in which retinal degeneration leads to incurable blindness. And since RP3 was near the DMD-inducing gene he was already working on, Swaroop figured it would be easy to transition to the field of eye research. While still at Yale, he wrote his first grant proposal to NIH: He proposed a novel strategy to identify genes for X-linked retinal diseases. NEI was impressed and funded him.

With a grant in hand, he went to the University of Michigan (Ann Arbor, Mich.) in 1990 to continue his eye research; he kept getting more and larger grants from NEI and other funding organizations. Finally in 2007, he came to NEI, where he established and now heads the Neurobiology-Neurodegeneration and Repair Laboratory. In his quest to find the genetic defects behind and treatments for retinal diseases, he collaborates with other NEI and NIH scientists as well as with other researchers within the United States and several other countries.

Swaroop is interested in retinal photoreceptors and the retinal pigment epithelium (RPE), which is key to photoreceptors’ survival. Abnormalities, dysfunction, and/or the death of retinal photoreceptors in retinal and macular degenerative diseases can cause irreversible vision loss.

The RPE is a barrier between the retina’s neural network and the blood and maintains retinal cell homeostasis by providing nourishment and removing debris. “RPE is like the queen” in a game of chess, he said. She protects her “king”—the photoreceptors. In chess, “if the queen is gone, in many cases it results in checkmate. [In the eye], if RPE is dead, photoreceptors are gone, too.”

Swaroop’s new project is the development of stem cell–based therapies to replace defective or dying photoreceptor cells. He and his collaborators pioneered this approach by successfully transplanting photoreceptor precursor cells into degenerating mouse retinas. His team discovered that these precursor cells were more likely to grow and be successfully integrated into the degenerating retina than were mature brain- and retina-derived stem cells. (Nature 444:203–207, 2006)

“We are particularly enthusiastic about Dr. Swaroop’s project to combine his wide expertise in genetics and genomics with iPS cell technology to understand early-onset retinal degeneration,” said NEI’s scientific director, Sheldon Miller. Swaroop is obtaining iPSC (induced pluripotent stem cell) lines from people with Leber congenital amaurosis (LCA), a rare genetic disorder that appears at birth and causes blindness through the degeneration of photoreceptor cells. The iPSCs from these people have mutations in the CEP290 gene.

One of Swaroop’s recent discoveries was that, in the mouse, a mutated version of Cep290 codes for a protein that interacts with the Mkks protein, which is important in the formation of the arms, legs, heart, and reproductive system. The combination of Cep290 and Mkks mutants improved the function of the retinal photoreceptors in mice with LCA-like early-onset retinal degeneration. Targeting one or more interacting proteins might provide a therapeutic approach for treating human retinal diseases. (J Clin Invest 122:1233–1245, 2012)

Swaroop ended his presentation to the scientific directors with a line from Helen Keller: “The only thing worse than being blind is having sight but no vision.” He continues to work furiously towards his own vision—a world in which retinal diseases do not result in blindness.

This page was last updated on Monday, May 2, 2022

  • Issue Overview
  • Features
    • Piecing Together the Autism Puzzle
    • Crowdsourcing
    • Eyes on the Goal
    • Collins: How Can We Do Better?
    • Tenacious Tara
    • Bike Commuting
  • Departments
    • From the Deputy Director for Intramural Research
    • News You Can Use
    • NIH in History
    • Research Briefs
    • Colleagues: Recently Tenured
    • The Training Page
    • The SIG Beat
    • Announcements
    • Laboratory Confessions
  • Issue Contents
  • Download this issue as a PDF

Catalyst menu

  • Current Issue
  • Previous Issues
  • About The NIH Catalyst
  • Contact The NIH Catalyst
  • Share Your Story
  • NIH Abbreviations

Catalyst links

  • Follow The NIH Catalyst

Subscribe Today!

Subscribe to The NIH Catalyst Newsletter and receive email updates.

Subscribe

Get IRP Updates

Subscribe

  • Email
  • Print
  • Share Twitter Facebook LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
    • Organization & Leadership
    • Our Programs
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
    • Principal Investigators
    • Accomplishments
    • Accelerating Science
    • Research in Action
    • Trans-IRP Research Resources
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Advancing Translational Science
    • Clinical Trials
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
  • Department of Health and Human Services
  • National Institutes of Health
  • USA.gov

Footer

  • Home
  • Contact Us
  • IRP Brand Materials
  • HHS Vulnerability Disclosure
  • Web Policies & Notices
  • Site Map
  • Search